3 Things Parents Should Know About the COVID-19 Vaccines and Children
Kids won’t be able to receive the vaccines for several more months.
Category: Vaccines
3 Things People with Allergies Need to Know About the COVID-19 Vacc...
If you have allergies, don’t assume you can’t get the shot.
The COVID-19 Vaccines Are Here—Now What?
Hope is on the horizon, but you still need to wear a mask.
Should Pregnant Women Receive a COVID-19 Vaccine?
What women who are pregnant or planning a pregnancy need to know.
4 Things We Have Learned from the Published COVID-19 Vaccine Trial ...
Understanding what the results from COVID vaccine trials mean for the pandemic.
The Science of mRNA Vaccines
Scientists are using this more efficient technology to create a strong immune response seen in other vaccines.
What We Know (and Don’t Know) About the COVID-19 Vaccines
A successful vaccine can help end the pandemic.
People Up to Age 45 Can Now Be Vaccinated for HPV
The HPV vaccine is now recommended for adults to prevent multiple strains of the virus.
Ask the Pediatrician: Baby Vaccines
Pediatrician Edward Pickens, MD, talks about why baby vaccines are a must.
Pregnant women should be included in Zika virus vaccine research, n...
The inclusion of pregnant women in Zika virus vaccine research is crucial to solving the international health crisis, according to new guidance published by UNC’s Center for Bioethics and two other universities.
Babies, Children's Health, Contagions, Fertility, Pregnancy, Research, Vaccines, Zika
‘Conversations with Innovators:’ UNC hematologist on promising drug...
Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.
UNC researchers discover new target for dengue virus vaccine
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.